Clinical Research Drug Trials Pharmacokinetics 
Drug Discovery World
FEBRUARY 20, 2023
Following this, the FDA granted Orphan Drug Designation to Avacta Group’s chemotherapy drug, AVA6000, for the treatment of soft tissue sarcoma. An ongoing Phase I clinical trial will assess the safety and pharmacokinetics of AVA6000, which has potential in a range of cancer types.
Alta Sciences
JULY 31, 2024
Regulatory organizations like Health Canada, the International Council for Harmonisation (ICH), and the European Medicines Agency (EMA) have long emphasized the importance of including diverse populations in clinical research. For example, elderly individuals are more prone to comorbidities, dementia, and functional decline.
Expert insights. Personalized for you.
130 
Let's personalize your content